Do complexing proteins provide mechanical protection for botulinum neurotoxins?

Abstract

Botulinum toxin (BT) consists of botulinum neurotoxin and complexing proteins (CPs). CPs might provide mechanical protection for botulinum neurotoxin. As incobotulinumtoxinA (INCO, Xeomin®) does not contain CPs, we wanted to compare its mechanical stability to that of onabotulinumtoxinA (ONA, Botox®) containing CPs. For this, ONA and INCO were reconstituted without mechanical stress (NS) and with mechanical stress (WS) generated by a recently introduced stress test. Potencies were then measured by the paralysis times (PTs) in the mouse diaphragm assay. ONA-PT was 75.8\u2009±\u200910.3\xa0min (n\u2009=\u20096) under NS and 116.7\u2009±\u200929.8\xa0min (n\u2009=\u20096) under WS (two-tailed t test, p\u2009=\u20090.002). Mechanical stress increased the ONA-PT by 35.0% on the Growth Percentage Index. INCO-PT was 66.0\u2009±\u20097.0\xa0min for NS and 76.0\u2009±\u20091.0\xa0min for WS (t test, p\u2009=\u20090.129). Mechanical stress increased the INCO-PT by 13.2% on the Growth Percentage Index. Our data show that mechanical stress inactivates a CP-containing BT drug, but not a CP-free BT drug. We conclude that CPs do not provide protection against mechanical stress, supporting the view that CPs are not necessary for therapeutic purposes.